Skip to content
OpenCapital
Earnings
Screener
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Vertex Pharmaceuticals
Business Segments
Business Segments
income (loss)
income (loss)
Vertex Pharmaceuticals
·
Business Segments
·
1 segment
·
Rolls up to
Net Income
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Business Segments
$646.3M
$1.03B
$1.08B
$1.19B
$1.03B
Total
$646.3M
$1.03B
$1.08B
$1.19B
$1.03B